Novel Biomarker of Collagen Degradation can Identify Patients Affected with both Axial Spondyloarthritis and Crohn's Disease

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com

Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com